Risk factors of breast intraductal lesions in patients without pathological nipple discharge

Shen,Leihua; Ye,Yuqin; Liu,Xin; Li,Weimin; Wei,Jingjing; Ke,Zirui; Yang,Shaojuan; Yang,Zhaoying

doi:10.3892/mco.2020.2108

Risk factors of breast intraductal lesions in patients without pathological nipple discharge

Authors:
- Leihua Shen
- Yuqin Ye
- Xin Liu
- Weimin Li
- Jingjing Wei
- Zirui Ke
- Shaojuan Yang
- Zhaoying Yang
View Affiliations

Affiliations: Department of General Surgery, Xi'an Central Hospital, Xi'an, Shaanxi 710004, P.R. China, Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Science and Education, Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong 518000, P.R. China, Department of Emergency Center, the First Hospital of Yulin, Yulin, Shaanxi 719000, P.R. China, Department of Pathology, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Department of Breast Surgery, Hubei Cancer Hospital, Wuhan, Hubei 430070, P.R. China, Department of Pathology, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Breast Surgery, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China
Published online on: August 10, 2020 https://doi.org/10.3892/mco.2020.2108
Article Number: 38
Copyright: © Shen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The majority of breast cancer arises from the ductal epithelium. It is crucial in the diagnosis and treatment of breast cancer by detecting intraductal lesions at an early stage. The typical clinical characteristic of intraductal lesions is pathological nipple discharge (PND), although many patients with intraductal lesions do not exhibit PND. It is a serious challenge for clinicians to detect patients with intraductal lesions without PND at an early stage. The aim of the present study was to investigate the risk factors associated with intraductal lesions in patients without PND. This retrospective database review, conducted between April 2016 and April 2017, included 370 lesions from 255 patients with intraductal lesions (intraductal papilloma, atypical intraductal hyperplasia, intraductal carcinoma in situ) and non‑intraductal lesions (fibroadenoma, adenosis, cysts, lobular carcinoma in situ), diagnosed through surgical pathology. The patients were divided into two groups based on pathological diagnosis and clinical parameters were evaluated using univariate and multivariate analyses. Univariate analysis revealed that 9 of 14 factors were statistically significant. Five factors were identified to be associated risk factors in patients without PND through the multivariate logistic regression analysis: Age between 35 and 49 years and age ≥50 years [odds ratio (OR)=4.749, 95% confidence interval (CI)=2.371‑9.513, P<0.001; OR=2.587, 95% CI=2.587‑14.891, P<0.001; respectively], non‑menstrual breast pain (OR=1.922, 95% CI=1.037‑3.564, P=0.038), breast duct dilatation as seen using ultrasonography (OR=9.455, 95% CI=3.194‑27.987, P<0.001), lesion distance from nipple ≤2 cm (OR=2.747, 95% CI=1.668‑4.526, P<0.001) and lesion size ≤1 cm (OR=1.903, 95% CI=1.155‑3.136, P=0.012). In conclusion, for patients without PND but with risk factors, such as the patient being >35 years, with non‑menstrual breast pain, breast duct ectasia, lesion distance from nipple ≤2 cm and lesion size ≤1 cm as seen using ultrasonography, clinicians should be highly concerned about the possibility of intraductal lesions, in order to prevent misdiagnosis and reduce the misdiagnosis rate.

View Figures

View References

1	Dundar MM, Badve S, Bilgin G, Raykar V, Jain R, Sertel O and Gurcan MN: Computerized classification of intraductal breast lesions using histopathological images. IEEE Trans Biomed Eng. 58:1977–1984. 2011.PubMed/NCBI View Article : Google Scholar
2	Yang L, Wu D and Fan ZM: Retrospective analysis of pathologic nipple discharge. Genet Mol Res. 14:1443–1449. 2015.PubMed/NCBI View Article : Google Scholar
3	Han Y, Li J, Han S, Jia S, Zhang Y and Zhang W: Diagnostic value of endoscopic appearance during ductoscopy in patients with pathological nipple discharge. BMC Cancer. 17(300)2017.PubMed/NCBI View Article : Google Scholar
4	Lang JE and Kuerer HM: Breast ductal secretions: Clinical features, potential uses, and possible applications. Cancer Control. 14:350–359. 2007.PubMed/NCBI View Article : Google Scholar
5	Escobar PF, Crowe JP, Matsunaga T and Mokbel K: The clinical applications of mammary ductoscopy. Am J Surg. 191:211–215. 2006.PubMed/NCBI View Article : Google Scholar
6	Montroni I, Santini D, Zucchini G, Fiacchi M, Zanotti S, Ugolini G, Manaresi A and Taffurelli M: Nipple discharge: Is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision. Breast Cancer Res Treat. 123:895–900. 2010.PubMed/NCBI View Article : Google Scholar
7	Maxwell AJ, Mataka G and Pearson JM: Benign papilloma diagnosed on image-guided 14 G core biopsy of the breast: Effect of lesion type on likelihood of malignancy at excision. Clin Radiol. 68:383–387. 2013.PubMed/NCBI View Article : Google Scholar
8	Sparks CA: Using ductoscopy to detect breast mass at an early stage. AORN J. 76:851–854. 2002.PubMed/NCBI View Article : Google Scholar
9	Dubowy A, Raubach M, Topalidis T, Lange T, Eulenstein S and Hünerbein M: Breast duct endoscopy: Ductoscopy from a diagnostic to an interventional procedure and its future perspective. Acta Chir Belg. 111:142–145. 2011.PubMed/NCBI View Article : Google Scholar
10	Shiino S, Tsuda H, Yoshida M, Jimbo K, Asaga S, Hojo T and Kinoshita T: Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features. Pathol Int. 65:293–300. 2015.PubMed/NCBI View Article : Google Scholar
11	Swapp RE, Glazebrook KN, Jones KN, Brandts HM, Reynolds C, Visscher DW and Hieken TJ: Management of benign intraductal solitary papilloma diagnosed on core needle biopsy. Ann Surg Oncol. 20:1900–1905. 2013.PubMed/NCBI View Article : Google Scholar
12	Li X, Weaver O, Desouki MM, Dabbs D, Shyum S, Carter G and Zhao C: Microcalcification is an important factor in the management of breast intraductal papillomas diagnosed on core biopsy. Am J Clin Pathol. 138:789–795. 2012.PubMed/NCBI View Article : Google Scholar
13	Chang JM, Moon WK, Cho N, Han W, Noh DY, Park IA and Jung EJ: Risk of carcinoma after subsequent excision of benign papilloma initially diagnosed with an ultrasound (US)-guided 14-gauge core needle biopsy: A prospective observational study. Eur Radiol. 20:1093–1100. 2010.PubMed/NCBI View Article : Google Scholar
14	Sakr R, Rouzier R, Salem C, Antoine M, Chopier J, Darai E and Uzan S: Risk of breast cancer associated with papilloma. Eur J Surg Oncol. 34:1304–1308. 2008.PubMed/NCBI View Article : Google Scholar
15	Fatemi Y, Hurley R, Grant C, Henrichsen T, Chen B and Ghosh K: Challenges in the management of giant intraductal breast papilloma. Clin Case Rep. 3:7–10. 2015.PubMed/NCBI View Article : Google Scholar
16	Sydnor MK, Wilson JD, Hijaz TA, Massey HD and Shaw de Paredes ES: Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology. 242:58–62. 2007.PubMed/NCBI View Article : Google Scholar
17	Yi W, Xu F, Zou Q and Tang Z: Completely removing solitary intraductal papillomas using the mammotome system guided by ultrasonography is feasible and safe. World J Surg. 37:2613–2617. 2013.PubMed/NCBI View Article : Google Scholar
18	Mosier AD, Keylock J and Smith DV: Benign papillomas diagnosed on large-gauge vacuum-assisted core needle biopsy which span <1.5 cm do not need surgical excision. Breast J. 19:611–617. 2013.PubMed/NCBI View Article : Google Scholar
19	Ward EM, DeSantis CE, Lin CC, Kramer JL, Jemal A, Kohler B, Brawley OW and Gansler T: Cancer statistics: Breast cancer in situ. CA Cancer J Clin. 65:481–495. 2015.PubMed/NCBI View Article : Google Scholar
20	Foote FW and Stewart FW: Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol. 17:491–496.3. 1941.PubMed/NCBI View Article : Google Scholar
21	Wen HY and Brogi E: Lobular carcinoma in situ. Surg Pathol Clin. 11:123–145. 2018.PubMed/NCBI View Article : Google Scholar
22	Yang WT and Zhu XZ: The introduction of 2012 WHO classification of tumours of the breast. Zhonghua Bing Li Xue Za Zhi. 42:78–80. 2013.(In Chinese). PubMed/NCBI View Article : Google Scholar
23	Zhu Y, Zhang S, Liu P, Lu H, Xu Y and Yang WT: Solitary intraductal papillomas of the breast: MRI features and differentiation from small invasive ductal carcinomas. AJR Am J Roentgenol. 199:936–942. 2012.PubMed/NCBI View Article : Google Scholar
24	Wang LC, DeMartini WB, Partridge SC, Peacock S and Lehman CD: MRI-detected suspicious breast lesions: Predictive values of kinetic features measured by computer-aided evaluation. AJR Am J Roentgenol. 193:826–831. 2009.PubMed/NCBI View Article : Google Scholar
25	Jung SY, Kang HS, Kwon Y, Min SY, Kim EA, Ko KL, Lee S and Kim SW: Risk factors for malignancy in benign papillomas of the breast on core needle biopsy. World J Surg. 34:261–265. 2010.PubMed/NCBI View Article : Google Scholar
26	Lewis JT, Hartmann LC, Vierkant RA, Maloney SD, Shane Pankratz V, Allers TM, Frost MH and Visscher DW: An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol. 30:665–672. 2006.PubMed/NCBI View Article : Google Scholar
27	Page DL, Salhany KE, Jensen RA and Dupont WD: Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer. 78:258–266. 1996.PubMed/NCBI View Article : Google Scholar
28	Glenn ME, Throckmorton AD, Thomison JB III and Bienkowski RS: Papillomas of the breast 15 mm or smaller: 4-Year experience in a community-based dedicated breast imaging clinic. Ann Surg Oncol. 22:1133–1139. 2015.PubMed/NCBI View Article : Google Scholar
29	Pareja F, Corben AD, Brennan SB, Murray MP, Bowser ZL, Jakate K, Sebastiano C, Morrow M, Morris EA and Brogi E: Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision. Cancer. 122:2819–2827. 2016.PubMed/NCBI View Article : Google Scholar
30	Chang JM, Moon WK, Cho N, Han W, Noh DY, Park IA and Jung EJ: Management of ultrasonographically detected benign papillomas of the breast at core needle biopsy. AJR Am J Roentgenol. 196:723–729. 2011.PubMed/NCBI View Article : Google Scholar
31	Rizzo M, Linebarger J, Lowe MC, Pan L, Gabram SG, Vasquez L, Cohen MA and Mosunjac M: Management of papillary breast lesions diagnosed on core-needle biopsy: Clinical pathologic and radiologic analysis of 276 cases with surgical follow-up. J Am Coll Surg. 214:280–287. 2012.PubMed/NCBI View Article : Google Scholar
32	Suh JS, Yoo KY, Kwon OJ, Yun IJ, Han SH, Noh DY and Choe KJ: Menstrual and reproductive factors related to the risk of breast cancer in Korea. Ovarian hormone effect on breast cancer. J Korean Med Sci. 11:501–508. 1996.PubMed/NCBI View Article : Google Scholar
33	Huang Y, Zhang X, Li W, Song F, Dai H, Wang J, Gao Y, Liu X, Chen C, Yan Y, et al: A meta-analysis of the association between induced abortion and breast cancer risk among Chinese females. Cancer Causes Control. 25:227–236. 2014.PubMed/NCBI View Article : Google Scholar
34	Arthur R, Wang Y, Ye K, Glass AG, Ginsberg M, Loudig O and Rohan T: Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease. Breast Cancer Res Treat. 165:623–631. 2017.PubMed/NCBI View Article : Google Scholar
35	Jung S, Egleston BL, Chandler DW, Van Horn L, Hylton NM, Klifa CC, Lasser NL, LeBlanc ES, Paris K, Shepherd JA, et al: Adolescent endogenous sex hormones and breast density in early adulthood. Breast Cancer Res. 17(77)2015.PubMed/NCBI View Article : Google Scholar
36	Noroozian M, Stein LF, Gaetke-Udager K and Helvie MA: Long-term clinical outcomes in women with breast pain in the absence of additional clinical findings: Mammography remains indicated. Breast Cancer Res Treat. 149:417–424. 2015.PubMed/NCBI View Article : Google Scholar
37	Preece PE, Baum M, Mansel RE, Webster DJ, Fortt RW, Gravelle IH and Hughes LE: Importance of mastalgia in operable breast cancer. Br Med J (Clin Res Ed). 284:1299–1300. 1982.PubMed/NCBI View Article : Google Scholar
38	Hsu HH, Yu JC, Hsu GC, Chang WC, Yu CP, Tung HJ, Tzao C and Huang GS: Ultrasonographic alterations associated with the dilatation of mammary ducts: Feature analysis and BI-RADS assessment. Eur Radiol. 20:293–302. 2010.PubMed/NCBI View Article : Google Scholar
39	Francis A, England D, Rowlands D and Bradley S: Breast papilloma: Mammogram, ultrasound and MRI appearances. Breast. 11:394–397. 2002.PubMed/NCBI View Article : Google Scholar
40	Zhu QL, Zhang J, Lai XJ, Wang HY, Xiao MS and Jiang YX: Characterisation of breast papillary neoplasm on automated breast ultrasound. Br J Radiol. 86(20130215)2013.PubMed/NCBI View Article : Google Scholar
41	Chang JM, Han W, Moon WK, Cho N, Noh DY, Park IA and Jung EJ: Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: Rate of malignancy based on subsequent surgical excision. Ann Surg Oncol. 18:2506–2514. 2011.PubMed/NCBI View Article : Google Scholar